Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

Optinose Expects FY23 XHANCE Net Revenues $62.0M-$68.0M, Q1 XHANCE Net Revenues $10.0M

By Benzinga Newsdesk
March 7, 8:05 AM
The Company expects XHANCE net revenues for the full year of 2023 to be between $62.0 to $68.0 million. XHANCE net revenues attributable to a launch as a treatment for patients with chronic sinusitis are

OPTN

Read More
1 minute read
  • Guidance
  • News

Squarespace Sees FY23 Revenue $955M-970M vs $949.40M Est

By Benzinga Newsdesk
March 7, 7:53 AM
For the full fiscal year 2023, Squarespace currently expects: Revenue of $955 million to $970 million, or year-over-year growth of 10% to 12%. Non-GAAP unlevered free cash flow

SQSP

Read More
1 minute read
  • Guidance
  • News

Westwater Expects The Total Phase I Capital Requirements Of $271M For Kellyton Graphite Plant; Boosts Planned Production Capacity For Its Phase II Expansion

By Benzinga Newsdesk
March 7, 7:37 AM
The Company now expects the total Phase I capital requirements for the Kellyton Graphite Plant to be approximately $271 million, resulting in: More than doubling the expected annual production of CSPG to 7,500

WWR

Read More
1 minute read
  • Guidance
  • News

Squarespace Sees Q1 Revenue Of $232M To $234M Vs $227.29M Estimate

By Benzinga Newsdesk
March 7, 7:31 AM
Non-GAAP unlevered free cash flow of $63 million to $65 million, which represents a margin of 27% and year-over-year growth of 41% at the midpoint.

SQSP

Read More
4 minute read
  • Earnings
  • Guidance
  • News

Reported Late Monday March 06, BlackBerry Reports Preliminary Q4 And Full FY23 Results; Q4 Revenue ~$151M; FY23 Revenue ~$656M; Will Provide FY24 Outlook On Upcoming Earnings Conference Call

By Happy Mohamed
March 7, 2:16 AM
Preliminary fiscal year 2023 revenue for BlackBerry is estimated to be approximately $656 million IoT business unit revenue expected to be approximately $206 million, representing 16% year over

BB

Read More
1 minute read
  • Guidance
  • News

Pactiv Evergreen Proves Adjusted EBITDA Guidance In The Range Of $755M-$780M For FY23 And ~$160M For Q1 Of 2023

By Happy Mohamed
March 7, 2:11 AM
Outlook The Company is unable to provide a reconciliation of forward-looking Adjusted EBITDA without unreasonable effort because of the uncertainty and potential variability in amount and timing of our restructuring,

PTVE

Read More
1 minute read
  • Guidance
  • News

RxSight Sees FY23 Revenue $78M-$83M Vs $76.7M Est

By Happy Mohamed
March 6, 5:07 PM
2023 Guidance Highlights Provided 2023 revenue guidance range of $78.0 million to $83.0 million, representing implied growth of 59% to 69% compared to

RXST

Read More
1 minute read
  • Guidance
  • Management
  • News

Exela Technologies Announces Updates To 2023 Operational Performance Improvement Objectives; Target Estimated Savings In The Range Of $65M-$75M For 2023

By Happy Mohamed
March 6, 9:47 AM
Target estimated savings in the range of $65-$75 million for 2023 Process automation, Work from Anywhere and Anytime solutions lead realignment IRVING, Texas, March 06, 2023 (GLOBE NEWSWIRE) -- Exela

XELA

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • News

Biodesix Sees FY23 Revenue Guidance Of $52M-$55M Vs. $52.51M Estimate

By Benzinga Newsdesk
March 6, 7:14 AM
Guidance represents anticipated 36-44% growth over 2022 total revenue from Lung Diagnostic testing, Biopharmaceutical Services and COVID-19 testing; Excluding 2022 COVID-19 testing

BDSX

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • News

Science 37 Sees FY23 Revenue Guidance Of $55M-$60M Vs. $73.66M Estimate

By Benzinga Newsdesk
March 6, 7:09 AM
The company expects adjusted EBITDA guidance of $(50.0) million to $(48.0) million.

SNCE

Posts pagination

Previous 1 … 473 474 475 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service